|
TAF3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.795000E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.369400E-01 |
| Normal-vs-Stage2 |
7.236200E-03 |
| Normal-vs-Stage3 |
1.72549999954974E-07 |
| Normal-vs-Stage4 |
6.755000E-04 |
| Stage1-vs-Stage2 |
5.348300E-02 |
| Stage1-vs-Stage3 |
1.08759999994934E-06 |
| Stage1-vs-Stage4 |
7.498200E-03 |
| Stage2-vs-Stage3 |
2.008000E-01 |
| Stage2-vs-Stage4 |
5.022600E-01 |
| Stage3-vs-Stage4 |
7.752000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.994300E-04 |
| Normal-vs-AfricanAmerican |
2.819700E-04 |
| Normal-vs-Asian |
4.234600E-01 |
| Caucasian-vs-AfricanAmerican |
5.829800E-02 |
| Caucasian-vs-Asian |
7.736400E-01 |
| AfricanAmerican-vs-Asian |
3.234800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.626400E-04 |
| Normal-vs-Female |
1.923440E-03 |
| Male-vs-Female |
8.136600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.285700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.938300E-02 |
| Normal-vs-Age(61-80Yrs) |
3.91450000000182E-05 |
| Normal-vs-Age(81-100Yrs) |
8.556500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.736200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.023200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.331000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.180200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.006180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.884000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.127700E-02 |
| Normal-vs-Grade 2 |
1.670040E-01 |
| Normal-vs-Grade 3 |
1.90290000001703E-06 |
| Normal-vs-Grade 4 |
5.966500E-04 |
| Grade 1-vs-Grade 2 |
4.696100E-02 |
| Grade 1-vs-Grade 3 |
1.561790E-04 |
| Grade 1-vs-Grade 4 |
7.959200E-03 |
| Grade 2-vs-Grade 3 |
1.68762999999128E-05 |
| Grade 2-vs-Grade 4 |
5.745000E-03 |
| Grade 3-vs-Grade 4 |
6.637800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.050000E-01 |
| Normal-vs-ccB subtype |
4.31729999972319E-07 |
| ccA subtype-vs-ccB subtype |
3.76580000516213E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.058280E-03 |
| Normal-vs-N1 |
6.615400E-03 |
| N0-vs-N1 |
4.510000E-01 |
|
|
